{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:26:47Z","timestamp":1767839207760,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T01:05:36Z","timestamp":1559955936000},"page":"805-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Histiocytic and Dendritic Cell Neoplasms"],"prefix":"10.1016","volume":"12","author":[{"given":"Zenggang","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/PAS.0b013e3181e5341a","article-title":"Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis","volume":"34","author":"Chen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2019.03.013_bib2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3324\/haematol.2009.021212","article-title":"Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity","volume":"95","author":"Ratei","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/PAS.0b013e318283099f","article-title":"Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation","volume":"37","author":"West","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.2013.181","article-title":"Langerhans cell histiocytosis in acute leukemias of ambiguous or myeloid lineage in adult patients: support for a possible clonal relationship","volume":"27","author":"Yohe","year":"2014","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/leu.2012.27","article-title":"Clonal relationship between langerhans cell histiocytosis and myeloid sarcoma","volume":"26","author":"Schmitt-Graeff","year":"2012","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib6","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","article-title":"Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases","volume":"24","author":"Shao","year":"2011","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","article-title":"Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms","volume":"65","author":"Go","year":"2014","journal-title":"Histopathology"},{"issue":"13","key":"10.1016\/j.path.2019.03.013_bib8","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.path.2019.03.013_bib9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.path.2019.03.013_bib10","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","article-title":"BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases","volume":"38","author":"Roden","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.03.013_bib12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/PAS.0000000000001057","article-title":"Frequency of MAP2K1, TP53, and U2AF1 mutations in BRAF-mutated langerhans cell histiocytosis: further characterizing the genomic landscape of LCH","volume":"42","author":"McGinnis","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/DAD.0000000000001250","article-title":"CyclinD1 is useful to differentiate langerhans cell histiocytosis from reactive langerhans cells","volume":"41","author":"Chatterjee","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"10.1016\/j.path.2019.03.013_bib15","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/annrheumdis-2013-204924","article-title":"BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease","volume":"74","author":"Cangi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"32","key":"10.1016\/j.path.2019.03.013_bib16","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1200\/JCO.2012.43.2260","article-title":"Erdheim-Chester disease harboring the BRAF V600E mutation","volume":"30","author":"Blombery","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.14284","article-title":"Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease","volume":"180","author":"Cohen Aubart","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2012.46.9676","article-title":"BRAF mutations in Erdheim-Chester disease","volume":"31","author":"Emile","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2016-09-740217","article-title":"Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations","volume":"129","author":"Nordmann","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/DAD.0000000000000793","article-title":"Histopathological and clinical findings in cutaneous manifestation of Erdheim-Chester disease and langerhans cell histiocytosis overlap syndrome associated with the BRAFV600E mutation","volume":"39","author":"Liersch","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","article-title":"Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation","volume":"124","author":"Hervier","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.semdp.2016.05.002","article-title":"Follicular dendritic cells and related sarcoma","volume":"33","author":"Facchetti","year":"2016","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5858\/arpa.2014-0374-RS","article-title":"Follicular dendritic cell sarcoma","volume":"140","author":"Wu","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00000478-199711000-00004","article-title":"Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases","volume":"21","author":"Lin","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.03.013_bib25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/PAS.0000000000001158","article-title":"Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome","volume":"42","author":"Walters","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pathol.2017.09.017","article-title":"Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease","volume":"50","author":"Quesada","year":"2018","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.6004\/jnccn.2015.0020","article-title":"Interdigitating dendritic cell sarcoma","volume":"13","author":"Pokuri","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.critrevonc.2013.05.006","article-title":"Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series","volume":"88","author":"Saygin","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.path.2019.03.013_bib29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/15384047.2015.1057359","article-title":"Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature","volume":"16","author":"Di Liso","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.anndiagpath.2015.02.008","article-title":"Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma","volume":"19","author":"O'Malley","year":"2015","journal-title":"Ann Diagn Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib31","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.3324\/haematol.2018.193490","article-title":"Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing MYC translocation","volume":"103","author":"Ochi","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.path.2019.03.013_bib32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/PAS.0000000000000678","article-title":"Spindle cell melanoma and interdigitating dendritic cell sarcoma: do they represent the same process?","volume":"40","author":"Stowman","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.013_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anndiagpath.2018.03.008","article-title":"Interdigitating dendritic cell sarcoma: clinicopathologic study of 8 cases with review of the literature","volume":"34","author":"Xue","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.013_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200106000-00003","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association","volume":"25","author":"Cheuk","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.013_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/his.12851","article-title":"Clinicopathological features of inflammatory pseudotumour-like follicular dendritic cell tumour of the abdomen","volume":"68","author":"Chen","year":"2016","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib36","first-page":"2421","article-title":"Clinicopathologic characteristics of inflammatory pseudotumor-like follicular dendritic cell sarcoma","volume":"7","author":"Ge","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2463\/mrms.2014-0052","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor\u00a0of the spleen: case report and review of the literature","volume":"14","author":"Kitamura","year":"2015","journal-title":"Magn Reson Med Sci"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clinimag.2014.12.021","article-title":"Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review","volume":"39","author":"Bui","year":"2015","journal-title":"Clin Imaging"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/PAS.0000000000000170","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions","volume":"38","author":"Li","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.013_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4132\/KoreanJPathol.2013.47.6.599","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen with extensive histiocytic granulomas and necrosis: a case report and literature review","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/pin.12057","article-title":"Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen: a report of six cases with increased IgG4-positive plasma cells","volume":"63","author":"Choe","year":"2013","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/10428194.2018.1492128","article-title":"Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma","volume":"60","author":"Kommalapati","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib44","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","article-title":"Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis","volume":"142","author":"Skala","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12185-010-0603-z","article-title":"Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma","volume":"92","author":"Mori","year":"2010","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.path.2019.03.013_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/dc.23285","article-title":"Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: a case of transdifferentiation from low-grade follicular lymphoma","volume":"43","author":"Mehrotra","year":"2015","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.013_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/PAS.0b013e3182098799","volume":"35","author":"Wang","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.03.013_bib48","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/leu.2015.193","article-title":"Independent development of lymphoid and histiocytic malignancies from a shared early precursor","volume":"30","author":"Waanders","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/PAI.0b013e3181897e8e","article-title":"Malignant histiocytoses\/disseminated histiocytic sarcoma with hemophagocytic syndrome in a patient with mediastinal germ cell tumor","volume":"17","author":"Shinoda","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib51","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3324\/haematol.2017.179150","article-title":"Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma","volume":"103","author":"Voruz","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.humpath.2011.04.028","article-title":"Indeterminate cell tumor of the spleen","volume":"43","author":"Chen","year":"2012","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.03.013_bib53","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/PAS.0b013e31818593d6","article-title":"Indeterminate cell tumor: a rare dendritic neoplasm","volume":"32","author":"Rezk","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejim.2015.03.004","article-title":"Erdheim-Chester disease","volume":"26","author":"Campochiaro","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","article-title":"Erdheim-Chester disease: a systematic review","volume":"95","author":"Cives","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0b013e32834d861d","article-title":"Erdheim-Chester disease","volume":"24","author":"Haroche","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rdc.2013.02.011","article-title":"Erdheim-Chester disease","volume":"39","author":"Haroche","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.revmed.2014.04.007","article-title":"Erdheim-Chester disease","volume":"35","author":"Haroche","year":"2014","journal-title":"Rev Med Interne"},{"issue":"9","key":"10.1016\/j.path.2019.03.013_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/1744666X.2015.1060857","article-title":"The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm","volume":"11","author":"Haroche","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.path.2019.03.013_bib61","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lpm.2016.02.025","article-title":"Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia","volume":"46","author":"Haroche","year":"2017","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.path.2019.03.013_bib62","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1148\/radiol.10090320","article-title":"Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings","volume":"255","author":"Drier","year":"2010","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/modpathol.2017.160","article-title":"The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort","volume":"31","author":"Ozkaya","year":"2018","journal-title":"Mod Pathol"},{"issue":"19","key":"10.1016\/j.path.2019.03.013_bib64","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.013_bib65","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2013-02-482984","article-title":"Detection of an NRAS mutation in Erdheim-Chester disease","volume":"122","author":"Diamond","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.013_bib66","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim-Chester disease with long-term high-dose interferon-alpha","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.path.2019.03.013_bib67","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.path.2019.03.013_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation-2015.1.571","article-title":"Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease","volume":"2015","author":"Haroche","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.path.2019.03.013_bib70","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1634\/theoncologist.2018-0295","article-title":"FDA approval summary: vemurafenib for the treatment of patients with Erdheim-Chester disease with the BRAFV600 mutation","volume":"23","author":"Oneal","year":"2018","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.path.2019.03.013_bib71","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2017-07-795054","article-title":"Erdheim-Chester disease: the \"targeted\" revolution","volume":"130","author":"Vaglio","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2019.03.013_bib72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00292-015-0043-x","article-title":"Histiocytic diseases in childhood and adolescence","volume":"36","author":"Vokuhl","year":"2015","journal-title":"Pathologe"},{"key":"10.1016\/j.path.2019.03.013_bib73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/asheducation-2015.1.559","article-title":"Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.path.2019.03.013_bib74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PAS.0000000000000362","article-title":"Cytokeratin-positive fibroblastic reticular cell tumor with follicular dendritic cell features: a case report and review of the literature","volume":"39","author":"Goto","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.013_bib75","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan","year":"2008","journal-title":"Blood"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:16Z","timestamp":1761748816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300303"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.013","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histiocytic and Dendritic Cell Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}